The focus of this application is to locate and identify one or more genes that cause hypertension-associated end-stage renal (H-ESRD) disease in the African American population. Hypertensive end-stage renal disease is one of the leading causes of kidney failure in the United States and it disproportionately affects African Americans. This application builds upon a genome scan in 264 African American families containing index cases with H-ESRD and their siblings with end-stage kidney failure. We will perform fine mapping of the regions with the strongest evidence of linkage in the genome scan analysis. Linkage support intervals defined by the fine mapping process will be prioritized based on the evidence for linkage in our sample and other published data. High priority regions will be surveyed for candidate genes that could contribute to hypertension and H-ESRD. These genes will be subjected to a focused high density single nucleotide polymorphism (SNP) mapping effort, block identification and tested for association (e.g., single locus and haplotype) under a case-control design. The case-control sample is independent of the genome scan sample. The signal locus and haplotype analyses should help identify individual polymorphisms and haplotypes that are in linkage disequilibrium with H-ESRD. We anticipate that an intensive genetic analysis for the identification of haplotype blocks will facilitate the search for polymorphisms. Mapping the genes that predispose to hypertensive kidney disease will provide a framework for identifying the pathways that initiate or promote renal failure and could ultimately lead to the development of novel medications to prevent or slow progression of hypertensive kidney failure in African Americans.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK070941-04
Application #
7623476
Study Section
Special Emphasis Panel (ZRG1-HOP-C (02))
Program Officer
Rasooly, Rebekah S
Project Start
2006-05-01
Project End
2011-09-21
Budget Start
2009-05-01
Budget End
2011-09-21
Support Year
4
Fiscal Year
2009
Total Cost
$411,314
Indirect Cost
Name
Wake Forest University Health Sciences
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
937727907
City
Winston-Salem
State
NC
Country
United States
Zip Code
27157
Freedman, Barry I; Julian, Bruce A (2018) Evaluation of Potential Living Kidney Donors in the APOL1 Era. J Am Soc Nephrol 29:1079-1081
Ma, Lijun; Divers, Jasmin; Freedman, Barry I (2018) Mechanisms of injury in APOL1-associated kidney disease. Transplantation :
Guan, Meijian; Keaton, Jacob M; Dimitrov, Latchezar et al. (2018) An Exome-wide Association Study for Type 2 Diabetes-Attributed End-Stage Kidney Disease in African Americans. Kidney Int Rep 3:867-878
Tucker, Bryan M; Freedman, Barry I (2018) Need to Reclassify Etiologies of ESRD on the CMS 2728 Medical Evidence Report. Clin J Am Soc Nephrol 13:477-479
Skorecki, Karl L; Lee, Jessica H; Langefeld, Carl D et al. (2018) A null variant in the apolipoprotein L3 gene is associated with non-diabetic nephropathy. Nephrol Dial Transplant 33:323-330
Keaton, Jacob M; Gao, Chuan; Guan, Meijian et al. (2018) Genome-wide interaction with the insulin secretion locus MTNR1B reveals CMIP as a novel type 2 diabetes susceptibility gene in African Americans. Genet Epidemiol 42:559-570
Santoriello, Dominick; Husain, Syed A; De Serres, Sacha A et al. (2018) Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allografts. Kidney Int 94:1189-1198
Freedman, Barry I; Limou, Sophie; Ma, Lijun et al. (2018) APOL1-Associated Nephropathy: A Key Contributor to Racial Disparities in CKD. Am J Kidney Dis 72:S8-S16
Palmer, Nicholette D; Ma, Lijun; Freedman, Barry I (2018) Have We Made ""Rapid Progress"" Understanding the Pathogenesis in Rapidly Progressive Glomerulonephritis? Am J Nephrol 48:190-192
Langefeld, Carl D; Comeau, Mary E; Ng, Maggie C Y et al. (2018) Genome-wide association studies suggest that APOL1-environment interactions more likely trigger kidney disease in African Americans with nondiabetic nephropathy than strong APOL1-second gene interactions. Kidney Int 94:599-607

Showing the most recent 10 out of 129 publications